As of Friday close, Hologic Inc.’s (NASDAQ:HOLX) stock was down -$0.25, moving down -0.33 percent to $75.93. The average number of shares traded per day over the past five days has been 2,492,780 shares. 1 time new highs have been achieved over the past 5 days, with a -$4.76 fall in that time frame. In the last twenty days, the average volume was 1,962,755, while in the previous 50 days, it was 1,681,358.
Since last month, HOLX stock retreated -2.68%. Shares of the company fell to $72.82 on 08/01/23, the lowest level in the past month. A 52-week high of $87.88 was reached on 05/01/23 after having rallying from a 52-week low of $59.78. Since the beginning of this year, HOLX’s stock price has risen by 1.50% or $1.12, and marked a new high 11 times. However, the stock has declined by -13.60% since its 52-week high.
HOLX stock investors should be aware that Hologic Inc. (HOLX) stock had its last reported insider trading activity 51 days ago on Jun 15. GARRETT SCOTT T, the Director of the company, disposed of 10,000 shares for $79.72 on Jun 15. It resulted in a $797,240 divestment by the insider. Mitchell Essex D sold 2,390 shares at an average price of $83.73 on May 05. The insider now owns 7,212 shares following the transaction. On Feb 07, Principal Accounting Officer COHN BENJAMIN JORDAN sold 9,128 shares at $85.28 apiece. The transaction was valued at $778,445.
Valuation Metrics
Right now, Hologic Inc. (HOLX) has a P/E ratio of about 25.32. The stock’s beta is 1.00. Besides these, the trailing price-to-sales (P/S) ratio of 4.59, the price-to-book (PB) ratio of 3.55, and the price-to-cash flow ratio of 22.15 may also be considered.
Financial Health
In the three months ended June 29, Hologic Inc.’s quick ratio stood at 3.70, while its current ratio was 4.40, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.53, and the total debt-to-equity ratio was 0.54. On the profitability front, the trailing twelve-month gross margin is 56.30% percent. In the year ended June 29, EBITDA margin amounted to 42.74%, whereas operating margins totaled 23.20%. Based on annual data, HOLX earned $3.0 billion in gross profit and brought in $4.86 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 17.50%. Return on equity (ROE) for the past 12 months was 14.90%.
In Hologic Inc.’s quarter-end financial report for June 29, it reported total debt of $2.79 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. HOLX’s revenue fell -1.86% to $1.03 billion during the quarter, while net income inched up to $984.4 million. While analysts expected Hologic Inc. to report $0.89 quarterly earnings, the actual figure was $0.93 per share, beating the consensus estimate by 4.50%. During the quarter, the company generated $82.6 million in EBITDA. The liabilities of Hologic Inc. were 4.16 billion at the end of its most recent quarter ended June 29, and its total debt was $2.84 billion. The value of shareholders’ equity is $244.94 million.
Technical Picture
This quick technical analysis looks at Hologic Inc.’s (HOLX) price momentum. With a historical volatility rate of 20.41%, the RSI 9-day stood at 31.15% on 04 August.
With respect to its five-day moving average, the current Hologic Inc. price is down by -5.90% percent or -$4.76. At present, HOLX shares trade -2.04% below its 20-day simple moving average and -3.03% percent below its 100-day simple moving average. However, the stock is currently trading approximately -5.58% below its SMA50 and +18.01% above its SMA200.
Stochastic coefficient K was 32.26% and Stochastic coefficient D was 34.29%, while ATR was 1.77. Given the Stochastic reading of 32.29% for the 14-day period, the RSI (14) reading has been calculated as 35.81%. As of today, the MACD Oscillator reading stands at -2.77, while the 14-day reading stands at -3.08.
Analyst Ratings
Needham upgraded its rating on Hologic Inc. (NASDAQ: HOLX) to a Buy in a note to investors on July 14, 2023. The analysts firm previously had a Hold rating on the stock.Hologic Inc. (HOLX) has been rated Overweight by analysts. According to 0 brokerage firms, HOLX is a sell, and 11 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Hologic Inc. stock as buy, with 8 recommending it as overweight.
With a median target price of $93.00, the current consensus forecast for the stock is $80.00 – $95.00. Based on these forecasts, analysts predict Hologic Inc. (HOLX) will achieve an average price target of $90.64.
